Home > Insider Trading > Filing (0001466049-10-000035)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Biodel Inc	BIOD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1218154	Scott Weisman	C/O Biodel Inc. 100 Saw Mill Road Danbury CT 06810		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-01	40,000	$4.50	298,136	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2010-03-02	20,000	$0.00	20,000	$4.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2017-03-01	No	4	A	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2009.
The amount does not include 107,873 shares held by The 1999 Weisman Family Trust, of which the undersigned and his spouse are trustees. The filing of this statement shall not be deemed an admission that the undersigned or his spouse is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of such shares.
This option will vest in twelve equal monthly installments on the last day of each month beginning on the date of grant.